For FY2023, the company increased its revenue by 11.2% y-o-y to $70 million and earnings by 3.3% y-o-y to $13.2 million, thanks to stronger demand for speciality eye care services in Singapore, Malaysia and other emerging countries in Southeast Asia.
ISEC Healthcare, a relatively low-profile SGX-listed healthcare counter, is gearing up for a big expansion with an eye on growing regional demand for its services while paying out a steady dividend income stream, says SAC Capital analysts June Yap and Matthias Chan in a non-rated note on March 18.
Incorporated in 2014, ISEC Healthcare (SGX:40T
) provides medical eye care services ranging from cataract, Lasik to complex corneal transplantation surgeries.
